American Public Education Inc (APEI) stock
Close on Nov 17, 2026Market cap $749.08MP/E 16.8Yield –
Earnings
American Public Education's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of American Public Education's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 11, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 9, 2026after the close | $169.10M | +3.6% | $0.32 | – | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 10, 2026after the close | $171.70M | +5.5% | $0.52 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026after the close | $174.70M | +6.1% | $0.94 | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 12, 2026after the close | $158.30M | -3.5% | $0.67 | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 10, 2025after the close | $163.20M | +6.6% | $0.30 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | $162.80M | +6.5% | -$0.02 | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 12, 2025after the close | $164.60M | +6.6% | $0.41 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 6, 2025after the close | $164.10M | +7.4% | $0.63 | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024after the close | $153.10M | +1.5% | $0.04 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 6, 2024after the close | $152.90M | +3.9% | -$0.06 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024after the close | $154.40M | +3.1% | -$0.06 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 5, 2024after the close | $152.80M | +0.3% | $0.64 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023after the close | $150.80M | +0.9% | -$0.27 | $0.02 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023after the close | $147.20M | -1.6% | -$2.93 | -$0.25 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023after the close | $149.70M | -3.2% | -$0.38 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 14, 2023after the close | $152.40M | -1.0% | -$0.35 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022after the close | $149.50M | +52.2% | -$0.20 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022after the close | $149.60M | – | -$5.82 | -$0.06 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 10, 2022after the close | $154.70M | – | $0.28 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 2, 2022after the close | $154.00M | – | $0.50 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 8, 2021after the close | $98.20M | – | -$0.01 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 9, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 10, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 24, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
American Public Education's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | Q4 FY2026 | $179.40M – $185.40M | – | New | Nov 9, 2026 |
| Adjusted EBITDAnon-GAAP | Q4 FY2026 | $30.60M – $37.60M | – | New | Nov 9, 2026 |
| Diluted Earnings per ShareGAAP | Q4 FY2026 | $0.81 – $1.07 | – | New | Nov 9, 2026 |
| Health+ Enrollment | Q4 FY2026 | 20,100 | – | Lowered | Nov 9, 2026 |
| Military+ Net Registrations | Q4 FY2026 | 100,000 – 105,000 | – | New | Nov 9, 2026 |
| Net Income Available to Common StockholdersGAAP | Q4 FY2026 | $15.20M – $19.80M | – | New | Nov 9, 2026 |
| RevenueGAAP | FY2026 | $695.00M – $701.00M | – | New | Nov 9, 2026 |
| Revenue | FY2026 | $686.00M – $696.00M | $685.00M – $695.00M | Raised | May 11, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $98.00M – $105.00M | – | New | Nov 9, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $93.00M – $102.00M | $91.50M – $100.50M | Raised | May 11, 2026 |
| Diluted Earnings per ShareGAAP | FY2026 | $2.59 – $2.84 | – | New | Nov 9, 2026 |
| Diluted Earnings per ShareGAAP | FY2026 | $2.33 – $2.68 | $2.15 – $2.47 | Raised | May 11, 2026 |
| Capital Expenditures | FY2026 | $23.00M – $26.00M | – | New | Nov 9, 2026 |
| Capital Expenditures | FY2026 | $28.00M – $32.00M | $28.00M – $32.00M | Reaffirmed | May 11, 2026 |
| Net Income Available to Common StockholdersGAAP | FY2026 | $48.50M – $53.20M | – | New | Nov 9, 2026 |
| Net Income Available to Common StockholdersGAAP | FY2026 | $41.30M – $47.60M | – | New | Mar 12, 2026 |
Guidance vs results
The last range American Public Education gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | EPS (GAAP) | $0.34 – $0.39 | $0.52 | Above range |
| Q2 FY2026 | Revenue | $170.00M – $172.00M | $171.70M | Within range |
| Q1 FY2026 | EPS (GAAP) | $0.58 – $0.64 | $0.94 | Above range |
| Q1 FY2026 | Revenue | $173.00M – $175.00M | $174.70M | Within range |
| Q4 FY2025 | EPS (GAAP) | $0.32 – $0.45 | $0.67 | Above range |
| Q4 FY2025 | Revenue | $150.00M – $153.50M | $158.30M | Above range |
| Q3 FY2025 | EPS (GAAP) | -$0.15 – -$0.04 | $0.30 | Above range |
| Q3 FY2025 | Revenue | $159.00M – $161.00M | $163.20M | Above range |
| Q2 FY2025 | EPS (GAAP) | -$0.13 – -$0.04 | -$0.02 | Above range |
| Q2 FY2025 | Revenue | $160.00M – $162.00M | $162.80M | Above range |
| Q4 FY2024 | EPS (GAAP) | $0.47 – $0.56 | $0.63 | Above range |
| Q4 FY2024 | Revenue | $159.00M – $164.00M | $164.10M | Above range |
| Q3 FY2024 | EPS (GAAP) | -$0.06 – $0.05 | $0.04 | Within range |
| Q3 FY2024 | Revenue | $152.00M – $155.00M | $153.10M | Within range |
| Q2 FY2024 | EPS (GAAP) | -$0.11 – $0.05 | -$0.06 | Within range |
| Q2 FY2024 | Revenue | $153.00M – $155.00M | $152.90M | Below range |
| Q1 FY2024 | EPS (GAAP) | -$0.25 – -$0.17 | -$0.06 | Above range |
| Q1 FY2024 | Revenue | $151.00M – $153.00M | $154.40M | Above range |
| Q4 FY2023 | EPS (GAAP) | $0.07 – $0.15 | $0.64 | Above range |
| Q4 FY2023 | Revenue | $149.30M – $151.30M | $152.80M | Above range |
| Q3 FY2023 | EPS (GAAP) | -$0.32 – -$0.24 | -$0.27 | Within range |
| Q3 FY2023 | Revenue | $148.30M – $150.30M | $150.80M | Above range |
| Q2 FY2023 | EPS (GAAP) | -$0.36 – -$0.28 | -$2.93 | Below range |
| Q2 FY2023 | Revenue | $145.50M – $147.50M | $147.20M | Within range |
| Q1 FY2023 | EPS (GAAP) | -$0.51 – -$0.44 | -$0.38 | Above range |
| Q1 FY2023 | Revenue | $155.10M – $157.10M | $149.70M | Below range |
| Q4 FY2022 | EPS (GAAP) | -$0.20 – -$0.13 | -$0.35 | Below range |
| Q4 FY2022 | Revenue | $151.20M – $154.20M | $152.40M | Within range |
| Q3 FY2022 | EPS (GAAP) | -$0.31 – -$0.24 | -$0.20 | Above range |
| Q3 FY2022 | Revenue | $145.10M – $148.10M | $149.50M | Above range |
| Q2 FY2022 | EPS (GAAP) | $0.00 – $0.07 | -$5.82 | Below range |
| Q2 FY2022 | Revenue | $150.00M – $154.00M | $149.60M | Below range |
| Q1 FY2022 | EPS (GAAP) | $0.12 – $0.17 | $0.28 | Above range |
| Q1 FY2022 | Revenue | $155.00M – $159.00M | $154.70M | Below range |
| Q4 FY2021 | EPS (GAAP) | $0.31 – $0.38 | $0.50 | Above range |
| Q4 FY2021 | Revenue | $150.00M – $155.00M | $154.00M | Within range |
Guidance history
Every forecast American Public Education put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 9, 2026 | Capital Expenditures | FY2026 | $23.00M – $26.00M | New |
| Nov 9, 2026 | Adjusted EBITDA | Q4 FY2026 | $30.60M – $37.60M | New |
| Nov 9, 2026 | Adjusted EBITDA | FY2026 | $98.00M – $105.00M | New |
| Nov 9, 2026 | Diluted Earnings per Share | Q4 FY2026 | $0.81 – $1.07 | New |
| Nov 9, 2026 | Diluted Earnings per Share | FY2026 | $2.59 – $2.84 | New |
| Nov 9, 2026 | Military+ Net Registrations | Q4 FY2026 | 100,000 – 105,000 | New |
| Nov 9, 2026 | Health+ Enrollment | Q4 FY2026 | 20,100 | Lowered |
| Nov 9, 2026 | Net Income Available to Common Stockholders | Q4 FY2026 | $15.20M – $19.80M | New |
| Nov 9, 2026 | Net Income Available to Common Stockholders | FY2026 | $48.50M – $53.20M | New |
| Nov 9, 2026 | Revenue | Q4 FY2026 | $179.40M – $185.40M | New |
| Nov 9, 2026 | Revenue | FY2026 | $695.00M – $701.00M | New |
| May 11, 2026 | Capital Expenditures | FY2026 | $28.00M – $32.00M | Reaffirmed |
| May 11, 2026 | Adjusted EBITDA | FY2026 | $93.00M – $102.00M | Raised |
| May 11, 2026 | Adjusted EBITDA | Q2 FY2026 | $16.50M – $18.00M | New |
| May 11, 2026 | Diluted Earnings per Share | FY2026 | $2.33 – $2.68 | Raised |
| May 11, 2026 | Diluted Earnings per Share | Q2 FY2026 | $0.34 – $0.39 | New |
| May 11, 2026 | Military+ Net registrations | Q2 FY2026 | 98,300 – 100,300 | New |
| May 11, 2026 | Health+ Enrollment | Q2 FY2026 | 19,600 | Lowered |
| May 11, 2026 | Revenue | FY2026 | $686.00M – $696.00M | Raised |
| May 11, 2026 | Revenue | Q2 FY2026 | $170.00M – $172.00M | New |
| Mar 12, 2026 | Capital Expenditures | FY2026 | $28.00M – $32.00M | New |
| Mar 12, 2026 | Adjusted EBITDA | FY2026 | $91.50M – $100.50M | New |
| Mar 12, 2026 | Adjusted EBITDA | Q1 FY2026 | $25.50M – $27.00M | New |
| Mar 12, 2026 | Diluted Earnings per Share | FY2026 | $2.15 – $2.47 | New |
| Mar 12, 2026 | Diluted Earnings per Share | Q1 FY2026 | $0.58 – $0.64 | New |
| Mar 12, 2026 | Net Income Available to Common Stockholders | FY2026 | $41.30M – $47.60M | New |
| Mar 12, 2026 | APU Global Net registrations | Q1 FY2026 | 106,600 | New |
| Mar 12, 2026 | RU Health+ Enrollment | Q1 FY2026 | 19,400 | Lowered |
| Mar 12, 2026 | Net Income Available to Common Stockholders | Q1 FY2026 | $11.10M – $12.20M | New |
| Mar 12, 2026 | Revenue | FY2026 | $685.00M – $695.00M | New |
| Mar 12, 2026 | Revenue | Q1 FY2026 | $173.00M – $175.00M | New |
| Nov 10, 2025 | APEI Capital Expenditure (CapEx) | FY2025 | $15.00M – $17.00M | Lowered |
| Nov 10, 2025 | APEI Adjusted EBITDA | Q4 FY2025 | $18.50M – $22.00M | New |
| Nov 10, 2025 | APEI Adjusted EBITDA | FY2025 | $75.00M – $79.00M | Lowered |
| Nov 10, 2025 | APEI Diluted EPS | Q4 FY2025 | $0.32 – $0.45 | New |
| Nov 10, 2025 | APUS Net course registrations | Q4 FY2025 | 65,000 – 74,400 | New |
| Nov 10, 2025 | HCN Student enrollment | Q4 FY2025 | 4000 | Lowered |
| Nov 10, 2025 | RU Student enrollment | Q4 FY2025 | 15,900 | Raised |
| Nov 10, 2025 | - On-ground Healthcare | Q4 FY2025 | 7100 | Lowered |
| Nov 10, 2025 | - Online | Q4 FY2025 | 8800 | Raised |
| Nov 10, 2025 | APEI Net income available to common stockholders | Q4 FY2025 | $5.90M – $8.30M | New |
| Nov 10, 2025 | APEI Net income available to common stockholders | FY2025 | $17.20M – $19.60M | Lowered |
| Nov 10, 2025 | APEI Consolidated revenue | Q4 FY2025 | $150.00M – $153.50M | New |
| Nov 10, 2025 | APEI Consolidated Revenue | FY2025 | $640.00M – $644.00M | New |
| Aug 6, 2025 | APEI Capital Expenditure (CapEx) | FY2025 | $18.00M – $22.00M | Reaffirmed |
| Aug 6, 2025 | APEI Adjusted EBITDA | FY2025 | $81.00M – $88.00M | Raised |
| Aug 6, 2025 | APEI Adjusted EBITDA | Q3 FY2025 | $15.00M – $17.00M | New |
| Aug 6, 2025 | APEI Diluted EPS | Q3 FY2025 | -$0.15 – -$0.04 | New |
| Aug 6, 2025 | - Online | Q3 FY2025 | 8200 | Raised |
| Aug 6, 2025 | RU Student enrollment | Q3 FY2025 | 14,900 | Raised |
| Aug 6, 2025 | APUS Net course registrations | Q3 FY2025 | 97,000 – 99,000 | New |
| Aug 6, 2025 | HCN Student enrollment | Q3 FY2025 | 3700 | Lowered |
| Aug 6, 2025 | - On-ground Healthcare | Q3 FY2025 | 6700 | Lowered |
| Aug 6, 2025 | APEI Consolidated revenue | Q3 FY2025 | $159.00M – $161.00M | New |
| Aug 6, 2025 | APEI Consolidated Revenue | FY2025 | $650.00M – $660.00M | Reaffirmed |
| May 12, 2025 | APEI Capital Expenditure (CapEx) | FY2025 | $18.00M – $22.00M | New |
| May 12, 2025 | APEI Adjusted EBITDA | Q2 FY2025 | $11.50M – $14.00M | New |
| May 12, 2025 | APEI Adjusted EBITDA | FY2025 | $77.00M – $87.00M | New |
| May 12, 2025 | APEI Diluted EPS | Q2 FY2025 | -$0.13 – -$0.04 | New |
| May 12, 2025 | EPS | FY2025 | $1.23 – $1.61 | New |
| May 12, 2025 | RU Student enrollment | Q2 FY2025 | 14,600 | Raised |
| May 12, 2025 | APUS Net course registrations | Q2 FY2025 | 93,500 – 96,100 | New |
| May 12, 2025 | HCN Student enrollment | Q2 FY2025 | 3700 | Lowered |
| May 12, 2025 | - On-ground Healthcare | Q2 FY2025 | 6400 | Lowered |
| May 12, 2025 | - Online | Q2 FY2025 | 8300 | Raised |
| May 12, 2025 | APEI Net loss/income available to common stockholders | Q2 FY2025 | -$2.50M – -$700.00K | New |
| May 12, 2025 | APEI Net income available to common stockholders | FY2025 | $23.00M – $30.00M | New |
| May 12, 2025 | APEI Consolidated Revenue | FY2025 | $650.00M – $660.00M | New |
| May 12, 2025 | APEI Consolidated revenue | Q2 FY2025 | $160.00M – $162.00M | New |
| Nov 12, 2024 | APEI Capital Expenditure (CapEx) | FY2024 | $19.00M – $22.00M | Raised |
| Nov 12, 2024 | APEI Adjusted EBITDA | Q4 FY2024 | $23.00M – $26.00M | New |
| Nov 12, 2024 | APEI Adjusted EBITDA | FY2024 | $64.00M – $67.00M | Narrowed |
| Nov 12, 2024 | APEI Diluted EPS | Q4 FY2024 | $0.47 – $0.56 | New |
| Nov 12, 2024 | APEI Net income available to common stockholders | FY2024 | $7.00M – $9.00M | Narrowed |
| Nov 12, 2024 | APEI Net loss/income available to common stockholders | Q4 FY2024 | $9.00M – $11.00M | New |
| Nov 12, 2024 | APUS Net course registrations | Q4 FY2024 | 94,400 – 96,100 | New |
| Nov 12, 2024 | HCN Student enrollment | Q4 FY2024 | 3700 | Lowered |
| Nov 12, 2024 | RU Student enrollment | Q4 FY2024 | 14,600 | Raised |
| Nov 12, 2024 | RU Student enrollment - On-ground Healthcare | Q4 FY2024 | 6300 | Lowered |
| Nov 12, 2024 | RU Student enrollment - Online | Q4 FY2024 | 8300 | Raised |
| Nov 12, 2024 | APEI Consolidated revenue | Q4 FY2024 | $159.00M – $164.00M | New |
| Nov 12, 2024 | APEI Consolidated Revenue | FY2024 | $620.00M – $625.00M | New |
| Aug 6, 2024 | APEI Capital Expenditure (CapEx) | FY2024 | $17.00M – $20.00M | Reaffirmed |
| Aug 6, 2024 | APEI Adjusted EBITDA | Q3 FY2024 | $9.00M – $12.00M | New |
| Aug 6, 2024 | APEI Adjusted EBITDA | FY2024 | $60.00M – $70.00M | Reaffirmed |
| Aug 6, 2024 | APEI Diluted EPS | Q3 FY2024 | -$0.06 – $0.05 | New |
| Aug 6, 2024 | APUS Net course registrations | Q3 FY2024 | 90,500 – 92,300 | New |
| Aug 6, 2024 | HCN Student enrollment | Q3 FY2024 | 3100 | Lowered |
| Aug 6, 2024 | RU Student enrollment 1 | Q3 FY2024 | 13,500 | Raised |
| Aug 6, 2024 | - On-ground Healthcare | Q3 FY2024 | 6030 | Lowered |
| Aug 6, 2024 | - Online | Q3 FY2024 | 7440 | Raised |
| Aug 6, 2024 | APEI Net loss/income available to common stockholders | Q3 FY2024 | -$1.20M – $1.00M | New |
| Aug 6, 2024 | APEI Net income available to common stockholders | FY2024 | $6.00M – $13.00M | Lowered |
| Aug 6, 2024 | APEI Consolidated revenue | Q3 FY2024 | $152.00M – $155.00M | New |
| Aug 6, 2024 | APEI Consolidated Revenue | FY2024 | $620.00M – $630.00M | Reaffirmed |
| May 7, 2024 | APEI Capital Expenditure (CapEx) | FY2024 | $17.00M – $20.00M | New |
| May 7, 2024 | APEI Adjusted EBITDA | Q2 FY2024 | $8.00M – $12.00M | New |
| May 7, 2024 | APEI Adjusted EBITDA | FY2024 | $60.00M – $70.00M | Raised |
| May 7, 2024 | APEI Diluted EPS | Q2 FY2024 | -$0.11 – $0.05 | New |
| May 7, 2024 | APUS Net course registrations | Q2 FY2024 | 89,500 – 92,200 | New |
| May 7, 2024 | HCN Student enrollment | Q2 FY2024 | 3300 | Lowered |
| May 7, 2024 | RU Student enrollment | Q2 FY2024 | 13,600 | Raised |
| May 7, 2024 | APEI Net loss/income available to common stockholders | Q2 FY2024 | -$2.00M – $800.00K | New |
| May 7, 2024 | APEI Net income available to common stockholders | FY2024 | $8.00M – $14.00M | New |
| May 7, 2024 | APEI Consolidated revenue | Q2 FY2024 | $153.00M – $155.00M | New |
| May 7, 2024 | APEI Consolidated Revenue | FY2024 | $620.00M – $630.00M | Raised |
| Mar 5, 2024 | APEI Capital Expenditure (CapEx) | FY2024 | $17.00M – $20.00M | New |
| Mar 5, 2024 | APEI Adjusted EBITDA | Q1 FY2024 | $8.00M – $10.00M | New |
| Mar 5, 2024 | APEI Adjusted EBITDA | FY2024 | $55.00M – $65.00M | New |
| Mar 5, 2024 | APEI Diluted EPS | Q1 FY2024 | -$0.25 – -$0.17 | New |
| Mar 5, 2024 | APUS Net course registrations | Q1 FY2024 | 97,000 – 99,000 | New |
| Mar 5, 2024 | HCN Student enrollment | Q1 FY2024 | 3300 | Lowered |
| Mar 5, 2024 | RU Student enrollment 1 | Q1 FY2024 | 13,500 | Raised |
| Mar 5, 2024 | - On-ground Healthcare | Q1 FY2024 | 6300 | Lowered |
| Mar 5, 2024 | - Online | Q1 FY2024 | 7200 | Raised |
| Mar 5, 2024 | APEI Net income available to common stockholders | Q1 FY2024 | -$4.40M – -$3.00M | New |
| Mar 5, 2024 | APEI Consolidated revenue | Q1 FY2024 | $151.00M – $153.00M | New |
| Mar 5, 2024 | APEI Consolidated Revenue | FY2024 | $610.00M – $620.00M | New |
| Nov 7, 2023 | APEI Adjusted EBITDA | Q4 FY2023 | $14.90M – $16.90M | New |
| Nov 7, 2023 | APEI Diluted EPS | Q4 FY2023 | $0.07 – $0.15 | New |
| Nov 7, 2023 | APUS Net course registrations | Q4 FY2023 | 88,900 – 90,700 | New |
| Nov 7, 2023 | HCN Student enrollment | Q4 FY2023 | 3100 | Lowered |
| Nov 7, 2023 | RU Student enrollment | Q4 FY2023 | 14,100 | Raised |
| Nov 7, 2023 | - Nursing | Q4 FY2023 | 5700 | Lowered |
| Nov 7, 2023 | - Non-Nursing | Q4 FY2023 | 8400 | Raised |
| Nov 7, 2023 | APEI Net income available to common stockholders | Q4 FY2023 | $1.30M – $2.70M | New |
| Nov 7, 2023 | APEI Consolidated revenue | Q4 FY2023 | $149.30M – $151.30M | New |
| Aug 8, 2023 | APEI Adjusted EBITDA | Q3 FY2023 | $8.40M – $10.40M | New |
| Aug 8, 2023 | APEI Diluted EPS | Q3 FY2023 | -$0.32 – -$0.24 | New |
| Aug 8, 2023 | APUS Net course registrations | Q3 FY2023 | 90.5 – 92.5 | New |
| Aug 8, 2023 | HCN Student enrollment | Q3 FY2023 | 2800 | Raised |
| Aug 8, 2023 | RU Student enrollment | Q3 FY2023 | 13,500 | Raised |
| Aug 8, 2023 | RU Student enrollment - Nursing | Q3 FY2023 | 5700 | Lowered |
| Aug 8, 2023 | RU Student enrollment - Non-Nursing | Q3 FY2023 | 7700 | Raised |
| Aug 8, 2023 | APEI Net loss available to common stockholders | Q3 FY2023 | -$5.70M – -$4.30M | New |
| Aug 8, 2023 | APEI Consolidated revenue | Q3 FY2023 | $148.30M – $150.30M | New |
| May 9, 2023 | APEI Adjusted EBITDA | Q2 FY2023 | $4.40M – $6.40M | New |
| May 9, 2023 | APEI Diluted EPS | Q2 FY2023 | -$0.36 – -$0.28 | New |
| May 9, 2023 | APUS Net course registrations | Q2 FY2023 | 85,300 – 88,700 | New |
| May 9, 2023 | RU Student enrollment | Q2 FY2023 | 13,900 | Raised |
| May 9, 2023 | - Nursing | Q2 FY2023 | 6400 | Lowered |
| May 9, 2023 | - Non-Nursing | Q2 FY2023 | 7500 | Raised |
| May 9, 2023 | APEI Net loss available to common stockholders | Q2 FY2023 | -$6.40M – -$5.00M | New |
| May 9, 2023 | HCN Student enrollment | Q2 FY2023 | 3000 | Lowered |
| May 9, 2023 | APEI Consolidated revenue | Q2 FY2023 | $145.50M – $147.50M | New |
| Mar 14, 2023 | APEI Adjusted EBITDA | Q1 FY2023 | $2.40M – $4.10M | New |
| Mar 14, 2023 | APEI Diluted EPS | Q1 FY2023 | -$0.51 – -$0.44 | New |
| Mar 14, 2023 | APUS Net course registrations | Q1 FY2023 | 96,300 | New |
| Mar 14, 2023 | HCN Student enrollment | Q1 FY2023 | 2700 | Lowered |
| Mar 14, 2023 | RU Student enrollment | Q1 FY2023 | 14,300 | Raised |
| Mar 14, 2023 | - Nursing | Q1 FY2023 | 6800 | Lowered |
| Mar 14, 2023 | - Non-Nursing | Q1 FY2023 | 7500 | Raised |
| Mar 14, 2023 | APEI Net loss available to common | Q1 FY2023 | -$9.70M – -$8.40M | New |
| Mar 14, 2023 | APEI Consolidated revenue | Q1 FY2023 | $155.10M – $157.10M | New |
| Nov 8, 2022 | APEI Adjusted EBITDA | Q4 FY2022 | $13.90M – $16.70M | New |
| Nov 8, 2022 | APEI Adjusted EBITDA | FY2022 | $55.20M – $58.00M | New |
| Nov 8, 2022 | APEI Diluted EPS | Q4 FY2022 | -$0.20 – -$0.13 | New |
| Nov 8, 2022 | APEI Diluted EPS | FY2022 | -$5.94 – -$5.87 | New |
| Nov 8, 2022 | APUS Net course registrations | Q4 FY2022 | 84,000 – 87,500 | New |
| Nov 8, 2022 | HCN Student enrollment | Q4 FY2022 | 2600 | Lowered |
| Nov 8, 2022 | RU Student enrollment | Q4 FY2022 | 15,600 | Raised |
| Nov 8, 2022 | - Nursing | Q4 FY2022 | 7600 | Lowered |
| Nov 8, 2022 | - Non-Nursing | Q4 FY2022 | 8000 | Raised |
| Nov 8, 2022 | APEI Consolidated net income | Q4 FY2022 | -$3.90M – -$2.40M | New |
| Nov 8, 2022 | APUS Net course registrations | FY2022 | 347,300 – 350,800 | New |
| Nov 8, 2022 | HCN Student enrollment | FY2022 | 2600 | Lowered |
| Nov 8, 2022 | RU Student enrollment | FY2022 | 15,600 | Raised |
| Nov 8, 2022 | - Nursing | FY2022 | 7600 | Lowered |
| Nov 8, 2022 | - Non-Nursing | FY2022 | 8000 | Raised |
| Nov 8, 2022 | APEI Consolidated net income | FY2022 | -$112.30M – -$110.90M | New |
| Nov 8, 2022 | APEI Consolidated revenue | Q4 FY2022 | $151.20M – $154.20M | New |
| Nov 8, 2022 | APEI Consolidated revenue | FY2022 | $605.10M – $608.10M | New |
| Aug 9, 2022 | APEI Adjusted EBITDA | Q3 FY2022 | $5.80M – $7.70M | New |
| Aug 9, 2022 | APEI Diluted EPS | Q3 FY2022 | -$0.31 – -$0.24 | New |
| Aug 9, 2022 | - Non-Nursing | Q3 FY2022 | 7300 | Lowered |
| Aug 9, 2022 | - Nursing | Q3 FY2022 | 7700 | Lowered |
| Aug 9, 2022 | APEI Consolidated net income | Q3 FY2022 | -$5.80M – -$4.50M | New |
| Aug 9, 2022 | HCN Student enrollment | Q3 FY2022 | 2410 | Lowered |
| Aug 9, 2022 | APUS Net course registrations | Q3 FY2022 | 83,100 – 87,200 | New |
| Aug 9, 2022 | RU Student enrollment | Q3 FY2022 | 15,000 | Raised |
| Aug 9, 2022 | APEI Consolidated revenue | Q3 FY2022 | $145.10M – $148.10M | New |
| May 10, 2022 | APEI Adjusted EBITDA | Q2 FY2022 | $14.30M – $16.20M | New |
| May 10, 2022 | APEI Diluted EPS | Q2 FY2022 | $0.00 – $0.07 | New |
| May 10, 2022 | - Non-Nursing | Q2 FY2022 | 7700 | Lowered |
| May 10, 2022 | - Nursing | Q2 FY2022 | 8200 | Lowered |
| May 10, 2022 | HCN Student enrollment | Q2 FY2022 | 2400 | Lowered |
| May 10, 2022 | APUS Net course registrations | Q2 FY2022 | 80,900 – 83,400 | New |
| May 10, 2022 | RU Student enrollment | Q2 FY2022 | 15,900 | Raised |
| May 10, 2022 | APEI Consolidated net income | Q2 FY2022 | $100.00K – $1.40M | New |
| May 10, 2022 | APEI Consolidated revenue | Q2 FY2022 | $150.00M – $154.00M | New |
| Mar 2, 2022 | APEI Adjusted EBITDA | Q1 FY2022 | $17.70M – $19.80M | New |
| Mar 2, 2022 | APEI Diluted EPS | Q1 FY2022 | $0.12 – $0.17 | New |
| Mar 2, 2022 | HCN Student enrollment | Q1 FY2022 | 2500 | Lowered |
| Mar 2, 2022 | APUS Net course registrations | Q1 FY2022 | 92,900 – 95,700 | New |
| Mar 2, 2022 | - Nursing | Q1 FY2022 | 8400 | Lowered |
| Mar 2, 2022 | RU Student enrollment | Q1 FY2022 | 16,200 | Raised |
| Mar 2, 2022 | APEI Consolidated net income | Q1 FY2022 | $2.30M – $3.30M | New |
| Mar 2, 2022 | - Non-Nursing | Q1 FY2022 | 7800 | Lowered |
| Mar 2, 2022 | APEI Consolidated revenue | Q1 FY2022 | $155.00M – $159.00M | New |
| Nov 8, 2021 | APEI Adjusted EBITDA | FY2021 | $59.00M – $61.50M | New |
| Nov 8, 2021 | APEI Adjusted EBITDA | Q4 FY2021 | $23.80M – $26.30M | New |
| Nov 8, 2021 | APEI Diluted EPS | FY2021 | $0.77 – $0.85 | New |
| Nov 8, 2021 | APEI Diluted EPS | Q4 FY2021 | $0.31 – $0.38 | New |
| Nov 8, 2021 | - Nursing | FY2021 | 8800 | Lowered |
| Nov 8, 2021 | APEI Consolidated net income | FY2021 | $14.10M – $15.50M | New |
| Nov 8, 2021 | - Non-Nursing | FY2021 | 8700 | Lowered |
| Nov 8, 2021 | RU Student enrollment | FY2021 | 17,500 | Raised |
| Nov 8, 2021 | HCN Student enrollment | FY2021 | 2510 | Lowered |
| Nov 8, 2021 | APUS Net course registrations | FY2021 | 342,600 – 345,200 | New |
| Nov 8, 2021 | APEI Consolidated net income | Q4 FY2021 | $5.70M – $7.10M | New |
| Nov 8, 2021 | - Non-Nursing | Q4 FY2021 | 8700 | Lowered |
| Nov 8, 2021 | - Nursing | Q4 FY2021 | 8800 | Lowered |
| Nov 8, 2021 | RU Student enrollment | Q4 FY2021 | 17,500 | Raised |
| Nov 8, 2021 | HCN Student enrollment | Q4 FY2021 | 2510 | Lowered |
| Nov 8, 2021 | APUS Net course registrations | Q4 FY2021 | 84,000 – 86,600 | New |
| Nov 8, 2021 | APEI Consolidated revenue | Q4 FY2021 | $150.00M – $155.00M | New |
| Nov 8, 2021 | APEI Consolidated revenue | FY2021 | $415.00M – $419.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases American Public Education filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
See a number that looks wrong?